Insights into MASH Enrollment amid increasing access to GLP-1 agonists TRACY HARDY, Senior Director, Head of Therapeutic Strategy and Innovation, Gastroenterology Center of Excellence
Insights into MASH Enrollment amid increasing access to GLP-1 agonists TRACY HARDY, Senior Director, Head of Therapeutic Strategy and Innovation, Gastroenterology Center of Excellence核心数据:in MASH faces challenges, with an 83% decrease in;trials. Unit sales of GLP-1s increased in the U.S. by 1,265%。
覆盖 2024 年,全文约 13。
本报告免费查阅,登录资料宝后即可在线获取完整内容。
适合战略规划、行业研究员等读者参考。
重点分析了管理咨询等议题。